Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CU.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CA.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.83NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.4 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.161NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.58NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.75NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-17028.5South Korea
B.1.411NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.217NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.17 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.41NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.527NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.500NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.147NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.487NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.68NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.121NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AS.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.115NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.127.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.88NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.168NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AH.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.289NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.365NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.252NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.223NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.640.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.11 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.428NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.355NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.34.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.71 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.33.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.52NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.465NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XFNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
S.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.221.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used